FacebookTwitterRedditEmail

Spinning Suicide Statistics

It’s been a busy year for pharma, creating new diseases to make healthy people take pills, reformulating existing drugs to win “new! improved!” patents, hiring high heel wearing reps to intercept the doc before ailing patients–and fear mongering suicide statistics to revive waning antidepressant prescriptions.

Long before the New York Times reported this month that youth suicides were up 8% from 2003 to 2004 and experts blamed an “antidepressant deficiency” big pharma was trying to plant the story.

There’s too much money in diagnosing children with major psychiatric illnesses and keeping them on psychotropic drugs their whole lives to let a little thing like the black box warnings the FDA imposed on antidepressants for children in 2004 ruin sales.

After all this is a nation that believes that children are born with a Ritalin deficiency, insomnia is Ambien deficiency and old age is hormone deficiency. Why shouldn’t pharmacology trump biology with suicide statistics as well?

Last year an article in the June issue of PLoS Medicine set the stage.

Lead author Dr. Julio Licinio, a consultant to Prozac-maker Eli Lilly, found the U.S. suicide rate “dropped steadily over 14 years as sales of the antidepressant [Prozac] rose.”

It was followed by an article in April in the Archives of General Psychiatry by four representatives of a private “drug development services” company called Quintiles Transnational and four other authors expressing concerns that “the number of children and teenagers who were prescribed antidepressants has decreased significantly” underlining “the importance of presenting a fair balance within the media.” (“Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United States”)

And in February a MedPage Today article actually scooped the New York Times with the headline, “Teen Suicide Spike Linked to SSRI Black Box.”

Black box warnings create a barrier to treatment “by scaring young people and parents away from care,” said David Shern, Ph.D., president of Mental Health America, reported to have accepted $3.8 million from pharmaceutical companies in 2005, in a statement when the article broke.

Charles Nemeroff, M.D., Ph.D., of Emory University School of Medicine took it a step further.

“The concerns about antidepressant use in children and adolescents have paradoxically resulted in a reduction in their use, and this has contributed to increased suicide rates,” he told reporters. Dr. Nemeroff has links to Eli Lilly, Pfizer, Wyeth-Ayerst, Pharmacia-Upjohn and five other drug makers according to published reports.

Unfortunately for pharma, when the New York Times broke the story it had a short shelf life.

The rise in suicides among ages 10 to 24 in 2003 to 2004 stood. But the charge that the rise was due to a drop-off in antidepressant prescriptions, especially selective serotonin reuptake inhibitors (SSRIs) like Prozac, which came from an article in the September American Journal of Psychiatry, promptly fell on its head.

It turned out the drop in SSRI prescriptions that “caused” the suicide rise occurred the following year. In most of the year cited, SSRI prescriptions actually “rose an average of just over 10 percent” for those 18 and under according to Psychiatric News and “the number of prescriptions peaked in March 2004.”

Meanwhile preliminary Centers for Disease Control and Prevention statistics from the year that would have been influenced by a drop in SSRI prescription that occurred–2005–do not show deaths up, though they have not been broken into category.

Asked about the 180% turnaround in facts which meant the suicide rise was not caused by SSRI prescription drop-offs and possibly caused by SSRIs themselves, vindicating the FDA’s black boxes, the article’s lead author Robert D. Gibbons, Ph.D., a professor of biostatistics and psychiatry at the University of Illinois at Chicago, did not sound the statistician.

“This study was suggestive, that’s what we’re saying,” Dr. Gibbons told the Times in a follow-up story–“Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents” is suggestive? try conclusive–and should piggyback off previous studies that showed the links better.

Then why publish it?

There were other question marks about the American Journal of Psychiatry article too–not counting Pfizer’s financial contribution and Dr. Gibbons link to Wyeth Pharmaceuticals.

What if the suicides aren’t about SSRIs at all but the growing popularity of treating children with antipsychotic drugs?

“I would be absolutely certain that the increase is not because kids are not being treated,” says David Healy, M.D., a psychiatrist at the University of Cardiff and early critic of SSRIs. “They may not be getting SSRIs, but they are getting psychotropics,” he says and, “the antipsychotic ‘mood stabilizers’ have just as great an increase in suicide risk as antidepressants–if not greater.”

Pharma is probably working on a new round of articles on the topic right now.

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

July 16, 2020
Vijay Prashad
Laos Has Tackled COVID-19, But It Is Drowning in Debt to International Finance
Louisa Willcox
Charlie Russell, Grizzly Whisperer
John McMurtry – Jeffery Klaehn
Money Capital vs Life Capital: the War of Values We Live or Die By
Jesse Jackson
A New Generation of Protest Holds Great Promise for America
Robert Hunziker
The Inertia Bugaboo
Jyoti Saraswati
Seeing the World Through Touch During a Pandemic
Sam Bahour
Time’s Up Israel: Get Your Knee Off Palestine’s neck
Nick Licata
How Protester Occupations Can Succeed
Dean Baker
It’s Going to be a Long, Hard Recession
Mary Miller – Ariel Gold
The U.S. Struggle for Justice for Palestine Begins a New Chapter
Rajan Menon
How the Pandemic Hit Americans: Selective in Its Impact, the Virus Has Struck the Homeless Hard
Chuck Collins
Fair Tax Solutions for Cities Facing Covid-19 Budget Crises
George Ochenski
The Times They are a-Changin’
Neil Decenteceo
Small Island Countries Aren’t Waiting for Rich Countries to Act on Climate
Binoy Kampmark
Blue Steak on Lygon Street: The Mario Corniola Effect
Nan Levinson
Veterans Go to Washington: So What?
July 15, 2020
Jennifer Loewenstein
Forging Greater Israel: Annexation by Any Other Name
John Davis
This is No Way to Live
Melvin Goodman
Bolton’s Book is Not the “Bomb” as Advertised
Kenneth Surin
Boris Johnson’s “Blundering Brilliance”…Now Only the Blundering Remains
Daniel Warner
Audacity and Hope in the Summer of Discontent
Thomas Klikauer – Nadine Campbell
Propaganda Beyond Trump
Omar Ramahi
Hagia Sophia and the Catastrophe of Symbolism
Binoy Kampmark
The Yeezy Effect: Kanye West Joins the Presidential Race
Robin Wonsley – Ty Moore
Minneapolis Ballot Measure to Dismantle the Police Will Test the Strength of Our Movement
Robert Jensen
‘Cancel Culture’ Cannot Erase a Strong Argument
Tom Clifford
Jack Charlton, Soccer and Ireland’s Working Class
Elliot Sperber
Mother Goose in the End Times
July 14, 2020
Anthony DiMaggio
Canceling the Cancel Culture: Enriching Discourse or Dumbing it Down?
Patrick Cockburn
Boris Johnson Should not be Making New Global Enemies When His Country is in a Shambles
Frank Joyce
Lift From the Bottom? Yes.
Richard C. Gross
The Crackdown on Foreign Students
Steven Salaita
Should We Cancel “Cancel Culture”?
Paul Street
Sorry, the Chicago Blackhawks Need to Change Their Name and Logo
Jonathan Cook
‘Cancel Culture’ Letter is About Stifling Free Speech, Not Protecting It
John Feffer
The Global Rushmore of Autocrats
C. Douglas Lummis
Pillar of Sand in Okinawa
B. Nimri Aziz
Soft Power: Americans in Its Grip at Home Must Face the Mischief It Wields by BNimri Aziz July 11/2020
Cesar Chelala
What was lost when Ringling Bros. Left the Circus
Dan Bacher
California Regulators Approve 12 New Permits for Chevron to Frack in Kern County
George Wuerthner
Shrinking Wilderness in the Gallatin Range
Lawrence Davidson
Woodrow Wilson’s Racism: the Basis For His Support of Zionism
Binoy Kampmark
Mosques, Museums and Politics: the Fate of Hagia Sophia
Dean Baker
Propaganda on Government Action and Inequality from David Leonhardt
July 13, 2020
Gerald Sussman
The Russiagate Spectacle: Season 2?
FacebookTwitterRedditEmail